d'Humières Camille, Gaïa Nadia, Gueye Signara, de Lastours Victoire, Leflon-Guibout Véronique, Maataoui Naouale, Duprilot Marion, Lecronier Marie, Rousseau Marc-Antoine, Gamany Naura, Lescure François-Xavier, Senard Olivia, Deconinck Laurène, Dollat Marion, Isernia Valentina, Le Hur Anne-Claire, Petitjean Marie, Nazimoudine Anissa, Le Gac Sylvie, Chalal Solaya, Ferreira Stéphanie, Lazarevic Vladimir, Guigon Ghislaine, Gervasi Gaspard, Armand-Lefèvre Laurence, Schrenzel Jacques, Ruppé Etienne
AP-HP, Hôpital Bichat, Service de Bactériologie, Paris, France.
INSERM, Université de Paris Cité, IAME, Paris, France.
Front Microbiol. 2022 Apr 21;13:863777. doi: 10.3389/fmicb.2022.863777. eCollection 2022.
Bone and joint infections (BJIs) are complex infections that require precise microbiological documentation to optimize antibiotic therapy. Currently, diagnosis is based on microbiological culture, sometimes complemented by amplification and sequencing of the 16S rDNA gene. Clinical metagenomics (CMg), that is, the sequencing of the entire nucleic acids in a sample, was previously shown to identify bacteria not detected by conventional methods, but its actual contribution to the diagnosis remains to be assessed, especially with regard to 16S rDNA sequencing. In the present study, we tested the performance of CMg in 34 patients (94 samples) with suspected BJIs, as compared to culture and 16S rDNA sequencing. A total of 94 samples from 34 patients with suspicion of BJIs, recruited from two sites, were analyzed by (i) conventional culture, (ii) 16S rDNA sequencing (Sanger method), and (iii) CMg (Illumina Technology). Two negative controls were also sequenced by CMg for contamination assessment. Based on the sequencing results of negative controls, 414 out of 539 (76.7%) bacterial species detected by CMg were considered as contaminants and 125 (23.2%) as truly present. For monomicrobial infections (13 patients), the sensitivity of CMg was 83.3% as compared to culture, and 100% as compared to 16S rDNA. For polymicrobial infections (13 patients), the sensitivity of CMg was 50% compared to culture, and 100% compared to 16S rDNA. For samples negative in culture (8 patients, 21 samples), CMg detected 11 bacteria in 10 samples from 5 different patients. In 5/34 patients, CMg brought a microbiological diagnosis where conventional methods failed, and in 16/34 patients, CMg provided additional information. Finally, 99 antibiotic resistance genes were detected in 24 patients (56 samples). Provided sufficient genome coverage (87.5%), a correct inference of antibiotic susceptibility was achieved in 8/8 bacteria (100%). In conclusion, our study demonstrated that the CMg provides complementary and potentially valuable data to conventional methods of BJIs diagnosis.
骨与关节感染(BJIs)是复杂的感染,需要精确的微生物学记录以优化抗生素治疗。目前,诊断基于微生物培养,有时辅以16S rDNA基因的扩增和测序。临床宏基因组学(CMg),即对样本中的全部核酸进行测序,此前已显示可鉴定出传统方法未检测到的细菌,但其对诊断的实际贡献仍有待评估,尤其是与16S rDNA测序相比。在本研究中,我们测试了CMg在34例疑似BJIs患者(94份样本)中的性能,并与培养和16S rDNA测序进行比较。从两个地点招募了34例疑似BJIs患者的94份样本,通过以下方法进行分析:(i)传统培养,(ii)16S rDNA测序(桑格法),以及(iii)CMg(Illumina技术)。还对两个阴性对照进行了CMg测序以评估污染情况。根据阴性对照的测序结果,CMg检测到的539种细菌中有414种(76.7%)被视为污染物,125种(23.2%)被视为真正存在。对于单一微生物感染(13例患者),与培养相比,CMg的敏感性为83.3%,与16S rDNA相比为100%。对于多微生物感染(13例患者),与培养相比,CMg的敏感性为50%,与16S rDNA相比为100%。对于培养阴性的样本(8例患者,21份样本),CMg在来自5名不同患者的10份样本中检测到11种细菌。在5/34例患者中,CMg在传统方法失败时做出了微生物学诊断,在16/34例患者中,CMg提供了额外信息。最后,在24例患者(56份样本)中检测到99个抗生素耐药基因。在提供足够的基因组覆盖率(87.5%)的情况下,8/8种细菌(100%)实现了抗生素敏感性的正确推断。总之,我们的研究表明,CMg为BJIs诊断的传统方法提供了补充性且可能有价值的数据。